Tag Archives: EU

Exclusive: EU denies blocking 3.1 million AstraZeneca shots to Australia

By Colin Packham

CANBERRA/BRUSSELS (Reuters) – The European Union on Tuesday denied blocking shipments of 3.1 million doses of AstraZeneca’s COVID-19 vaccine to Australia, as the bloc steps up scrutiny of vaccine exports to address shortages.

An Australian government source told Reuters that the EU had blocked 3.1 million shots and the country had little hope of getting the remaining 400,000 doses it has been promised on time.

The dispute underscores massive shortfalls of the AstraZeneca shot across the EU and complicates Australia’s inoculation campaign, which is more than 80% behind its original schedule.

“We cannot confirm any new decision to block vaccine exports to Australia or to any other country,” a European Commission spokesman told a news conference.

A Commission spokeswoman said the bloc had rejected only one of 491 COVID-19 vaccine export requests since it enhanced export transparency in late January, but added that seven requests were currently being reviewed – and therefore shipments were on hold until a decision was made.

She declined to say whether a new shipment to Australia was among those being reviewed. But an EU official said there was no request for export to Australia under review.

The only rejected request out of nearly 500 received has been so far a shipment of 250,000 doses to Australia in March. From Jan 30 to March 24, the EU exported 1 million doses to Australia, the Commission said in a press release.

The EU has repeatedly said that AstraZeneca may not be allowed to export from the EU until it fulfils its contractual obligations towards the bloc, a position that has led the company to refrain from submitting some export requests.

AstraZeneca did not immediately reply to a request for comment on Tuesday.

With inoculation rollouts running far behind those of Britain and the United States, the EU tightened its oversight of vaccine exports last month, giving it greater scope to block shipments. “They’ve blocked 3.1 million shots so far,” said the Australian government source, adding that it had only received 300,000 doses and a further 400,000 doses were scheduled to arrive by the end of April.

“We haven’t given up hope but we’ve stopped counting them in our expected supplies,” the source said. The person declined to be named because he is not authorized to talk about the matter.

WELL BEHIND SCHEDULE

Australia had until Tuesday only confirmed the block of 250,000 AstraZeneca doses from the EU, which Canberra said then would not delay its inoculation timetable.

An EU official said it was not responsible for AstraZeneca’s failure in upholding commitments to other countries. The drug maker aims to deliver only 100 million doses to the bloc by the end of June out of 300 million it had pledged.

It is unclear whether Australia plans to ask Britain or the United States to ship AstraZeneca doses.

Australian Prime Minister Scott Morrison said on Tuesday the missing shipments were responsible for it not meeting its inoculation schedule. “In early January, we anticipated we would have the 3.1 million vaccines. Those vaccines were not supplied to Australia,” Morrison told reporters in Canberra. “That is the reason.”

The AstraZeneca vaccine arriving from Europe were to underpin the early stages of Australia’s vaccine drive, supplementing 50 million shots of the vaccine that will be produced locally by CSL Ltd.

Australia has recorded just 909 coronavirus deaths since the pandemic began and said on Tuesday it would launch a quarantine and COVID-testing free travel bubble with New Zealand this month after effectively eradicating the virus by closing borders last year.

Australia’s vaccine program is running well behind schedule, having started much later than some other countries due to the low case numbers, and the AstraZeneca blockages leave it struggling to step up the pace.

Only about 670,000 people have been inoculated against an initial target of 4 million by end-March.

While the government blamed the slow rollout for supply issues from Europe, Australian state governments have also complained about slower-than-expected distribution and a lack of certainty on supplies.

(Reporting by Colin Packham and Renju Jose; Additional reporting by Francesco Guarascio in Brussels; Editing by Miyoung Kim, Nick Macfie and John Stonestreet)

EU official urges Greece to investigate asylum-seeker pushbacks

ATHENS (Reuters) – Greece “can do more” to investigate allegations that it is pushing asylum-seekers, including children, back to Turkey, the European Union’s top migration official said on Monday.

The United Nations refugee agency UNHCR has said it has received a growing number of reports in recent months suggesting asylum-seekers may have been pushed back to Turkey at sea or immediately after reaching Greek soil, or left adrift at sea.

Greek officials have always rejected the reports.

“I am very concerned about the UNHCR report and there are some specific cases that I really think need to be looked into closer,” Ylva Johansson, the EU’s home affairs commissioner, said during a visit to the island of Lesbos.

“I think the Greek authorities can do more when it comes to investigating these alleged pushbacks.”

Greek Minister Notis Mitarachi, speaking at a news conference with Johansson, said Greece adhered to European and international law.

“We strongly deny that the Greek coast guard has ever been involved in pushbacks,” he said.

“We understand we are causing a loss of tens of millions of euros to smuggling networks, and that could have played a role in the kind of fake news we hear about the Greek coast guard,” he said.

Mitarachi said independent investigations, including by the Greek judiciary and by the EU’s border agency Frontex, had not found violations.

In 2015 Greece, and Lesbos in particular, was at the frontline of Europe’s refugee crisis with nearly a million people, mostly Syrians fleeing war, arriving by boat from Turkey.

Numbers have decreased dramatically since the EU struck a deal with Ankara a year later and just over 16,000 people arrived in Greece last year, according to U.N. data.

Mitarachi said about 14,000 migrants were currently in camps on five islands, down from about 42,000 in 2019. About 58,000 were in camps across Greece, down from 92,000 in 2019.

(Reporting by Karolina Tagaris; Editing by Giles Elgood)

Myanmar junta blames protesters as EU, U.S. impose sanctions

(Reuters) – Myanmar’s military accused anti-junta protesters of arson and violence as Western countries imposed more sanctions on individuals and groups linked to last month’s coup and the ensuing bloody crackdown on dissent.

Junta spokesman Zaw Min Tun said 164 protesters had been killed in the violence and expressed sadness at the deaths.

“They are also our citizens,” he told a news conference in the capital Naypyitaw on Tuesday, adding that the military would use the least force possible to quell violence.

The Assistance Association for Political Prisoners (AAPP) activist group says at least 261 people have been killed in the brutal crackdown by security forces that has left the Southeast Asian nation in turmoil.

Three people including a teenage boy were killed in unrest on Monday in Myanmar’s second city, Mandalay, witnesses and news reports said.

The junta has tried to justify the coup by saying a Nov. 8 election won by Aung San Suu Kyi’s National League for Democracy (NLD) was fraudulent – an accusation the electoral commission rejected. Military leaders have promised a new election but have not set a date and have declared a state of emergency.

Zaw Min Tun blamed protesters for violence and arson and said nine members of the security forces had been killed.

“Can we call these peaceful protesters?” he said, while showing a video of factories on fire. “Which country or organization would regard this violence as peaceful?”

He said strikes and hospitals not fully operating had caused deaths, including from COVID-19, calling them “undutiful and unethical”.

The spokesman also accused media of “fake news” and fanning unrest and said reporters could be prosecuted if they were in contact with the CRPH, as the remnants of Suu Kyi’s government is known locally. The military has declared the CRPH an illegal organization and said membership is punishable by death.

In the over three hour news conference, the spokesman also said the military respected the media and although reporting protests was allowed, leading them was a crime.

Zaw Min Tun gave granular details or how the NLD had created hundreds or even thousands of extra ballots in numerous townships by inventing voters, including in Suu Kyi’s own constituency. Videos of people saying they were paid by NLD representatives were shown at the news conference.

Also shown was video testimony of former Yangon chief minister Phyo Min Thein saying he visited Suu Kyi multiple times and gave her money “whenever needed.”

Suu Kyi, who won the Nobel Peace Prize for her campaign to bring democratic civilian rule to Myanmar, has been in detention since the coup. Her lawyer says charges against her are trumped up.

‘UNBEARABLE EXTENT’

The European Union and the United States imposed sanctions on Monday against individuals involved in the coup and the repression of the demonstrators.

The EU sanctions were the bloc’s most significant response since the overthrow of Suu Kyi’s elected government on Feb. 1.

The 11 people it targeted included General Min Aung Hlaing, the commander-in-chief of the Myanmar military and head of the junta that has taken power.

The EU already has an arms embargo on Myanmar and has targeted some senior military officials since 2018.

German Foreign Minister Heiko Maas told reporters before the meeting that the military repression “has reached an unbearable extent”.

Washington had already sanctioned Min Aung Hlaing and the measures announced on Monday expanded the list.

There was no immediate response from the junta, which has shown no sign so far of being swayed by international condemnation of its actions.

Myanmar’s neighbors are also speaking out against the violence, which is rare for countries in the region.

“We believe violence against unarmed civilians is inexcusable,” Singapore Foreign Minister Vivian Balakrishnan said in Kuala Lumpur after talks with his Malaysian counterpart.

“We still believe there should be no external interference in the domestic affairs of a country, but to the maximum extent possible…we stand ready to do our best to support the people of Myanmar who in fact deserve so much better in the future.”

The junta said it is cooperating with five neighboring countries – Bangladesh, China, India, Laos and Thailand – and values and respects their words, plus any countries that respect the stability of Myanmar.

(Reporting by Reuters Staff; Writing by Ed Davies and Raju Gopalakrishnan; Editing by Simon Cameron-Moore)

EU imposes China sanctions over Xinjiang abuses; first in three decades

By Robin Emmott

BRUSSELS (Reuters) – The European Union imposed sanctions on Monday on four Chinese officials, including a top security director, for human rights abuses in Xinjiang, the first sanctions against Beijing since an arms embargo in 1989 following the Tiananmen Square crackdown.

Accused of mass detentions of Muslim Uighurs in northwestern China, those targeted with sanctions included Chen Mingguo, the director of the Xinjiang Public Security Bureau. The EU said Chen was responsible for “serious human rights violations.”

In its Official Journal, the EU accused Chen of “arbitrary detentions and degrading treatment inflicted upon Uighurs and people from other Muslim ethnic minorities, as well as systematic violations of their freedom of religion or belief”.

Others hit with travel bans and asset freezes were: senior Chinese officials Wang Mingshan and Wang Junzheng, the former head of China’s Xinjiang region, Zhu Hailun, and the Xinjiang Production and Construction Corps Public Security Bureau.

China denies any human rights abuses in Xinjiang and says its camps provide vocational training and are needed to fight extremism.

While mainly symbolic, the sanctions mark a significant hardening in the EU’s policy towards China, which Brussels long regarded as a benign trading partner but now views as a systematic abuser of basic rights and freedoms.

They are also likely to inflame tensions between Brussels and Beijing. The EU had not sanctioned China since it imposed an arms embargo in 1989 following the Tiananmen Square pro-democracy crackdown. The arms embargo is still in place.

All 27 EU governments agreed to the punitive measures, but Hungary’s foreign minister, Peter Szijjarto, called them “harmful” and “pointless,” reflecting the bloc’s divisions on how to deal with China’s rise and to protect business interests.

China is the EU’s second-largest trading partner after the United States and Beijing is both a big market and a major investor which has courted poorer and central European states.

POSSIBLE RETALIATION

But the EU, which sees itself as a champion of human rights, is deeply worried about the fate of the Uighurs. Britain, Canada and the United States have also expressed serious concerns.

Activists and U.N. rights experts say at least 1 million Muslims are being detained in camps in the remote western region of Xinjiang. The activists and some Western politicians accuse China of using torture, forced labor and sterilizations.

The EU’s sanctions take aim at officials who are seen to have designed and enforced the detentions in Xinjiang and come after the Dutch parliament followed Canada and the United States in labelling China’s treatment of the Uighurs as genocide, which China rejects.

Last week, China’s ambassador to the bloc, Zhang Ming, said that sanctions would not change Beijing’s policies, decrying the measures as confrontational and warning of retaliation.

The EU has also called for the release of jailed ethnic Uighur economics professor Ilham Tohti, who was jailed for life in 2014. He was awarded the European Parliament’s human rights prize in 2019.

(Reporting by Robin Emmott, Editing by William Maclean)

Germany, Italy, France to halt AstraZeneca shots, further hitting EU vaccination campaign

By Thomas Escritt and Stephanie Nebehay

BERLIN/GENEVA (Reuters) – Germany, France and Italy said on Monday they would stop administering the AstraZeneca COVID-19 vaccine after several countries reported possible serious side-effects, throwing Europe’s already struggling vaccination campaign into disarray.

Denmark and Norway stopped giving the shot last week after reporting isolated cases of bleeding, blood clots and a low platelet count. Iceland and Bulgaria followed suit and Ireland and the Netherlands announced suspensions on Sunday.

The moves by some of Europe’s largest and most populous countries will deepen concerns about the slow rollout of vaccines in the region, which has been plagued by shortages due to problems producing vaccines, including AstraZeneca’s.

Germany warned last week it was facing a third wave of infections, Italy is intensifying lockdowns and hospitals in the Paris region are close to being overloaded.

German Health Minister Jens Spahn said that although the risk of blood clots was low, it could not be ruled out.

“This is a professional decision, not a political one,” Spahn said adding he was following a recommendation of the Paul Ehrlich Institute, Germany’s vaccine regulator.

France said it was suspending the vaccine’s use pending an assessment by the EU medicine regulator due on Tuesday. Italy said its halt was a “precautionary and temporary measure” pending the regulator’s ruling.

Austria and Spain have stopped using particular batches and prosecutors in the northern Italian region of Piedmont earlier seized 393,600 doses following the death of a man hours after he was vaccinated. It was the second region to do so after Sicily, where two people had died shortly after having their shots.

The World Health Organization appealed to countries not to suspend vaccinations against a disease that has caused more than 2.7 million deaths worldwide.

“As of today, there is no evidence that the incidents are caused by the vaccine and it is important that vaccination campaigns continue so that we can save lives and stem severe disease from the virus,” WHO spokesman Christian Lindmeier said.

The United Kingdom said it had no concerns, while Poland said it thought the benefits outweighed any risks.

“UNUSUAL” SYMPTOMS

AstraZeneca’s shot was among the first and cheapest to be developed and launched at volume since the coronavirus was first identified in central China at the end of 2019 and is set to be the mainstay of vaccination programs in much of the developing world.

Thailand announced plans on Monday to go ahead with the Anglo-Swedish firm’s shot after suspending its use on Friday but Indonesia said it would wait for the WHO to report.

The WHO said its advisory panel was reviewing reports related to the shot and would release its findings as soon as possible. But it said it was unlikely to change its recommendations, issued last month, for widespread use, including in countries where the South African variant of the virus may reduce its efficacy.

The European Medicines Agency (EMA) has also said there was no indication the events were caused by the vaccination and that the number of reported blood clots was no higher than seen in the general population.

The handful of reported side-effects in Europe have upset vaccination programs already under pressure over slow rollouts and vaccine skepticism in some countries.

The Netherlands said on Monday it had seen 10 cases of possible noteworthy adverse side-effects from the AstraZeneca vaccine, hours after the government put its vaccination program on hold following reports of potential side-effects in other countries.

Denmark reported “highly unusual” symptoms in a 60-year-old citizen who died from a blood clot after receiving the vaccine, the same phrase used on Saturday by Norway about three people under the age of 50 it said were being treated in hospital.

“It was an unusual course of illness around the death that made the Danish Medicines Agency react,” the agency said in a statement late on Sunday.

One of the three health workers hospitalized in Norway after receiving the AstraZeneca shot had died, health authorities said on Monday, but there was no evidence that the vaccine was the cause. They said they would continue their probe and that no more suspected cases had been reported since Saturday.

AstraZeneca said earlier it had conducted a review covering more than 17 million people vaccinated in the European Union and the UK which had shown no evidence of an increased risk of blood clots.

Investigations into potential side-effects are complicated as the history of each case and circumstances surrounding a death or illness are examined. Austrian authorities have said their review of the AstraZeneca batch will take about two weeks.

The EMA has said that as of March 10, a total of 30 cases of blood clotting had been reported among close to 5 million people vaccinated with the AstraZeneca shot in the European Economic Area, which links 30 European countries.

The WHO said that as of March 12, more than 300 million doses of COVID-19 vaccines had been administered around the world with no deaths found to have been caused by any of them.

(Reporting by Panarat Thepgumpanat in BANKOK and Andreas Rinke and Paul Carrel in BERLIN, Angelo Amante in ROME, Christian Lowe in PARIS, Toby Sterling in AMSTERDAM, Jacob Gronholt-Pedersen in COPENHAGEN and Stanley Widianto in JAKARTA; writing by Philippa Fletcher; editing by Nick Macfie)

EU, under pressure over vaccine rollouts, considers switch to emergency approvals

By Francesco Guarascio

BRUSSELS (Reuters) – The European Commission said on Tuesday that it was considering emergency approvals for COVID-19 vaccines as a faster alternative to more rigorous conditional marketing authorizations which have been used so far.

The move would mark a big shift in approach to vaccine approvals, as it would entail using a procedure that the EU had considered dangerous and that before the COVID-19 pandemic had been reserved for exceptional authorization at national level of drugs for terminally ill patients, including cancer treatments.

The potential change comes as the EU executive and the bloc’s drug regulator come under increasing pressure for what some consider slow vaccine approvals, which have contributed to a slower rollout of COVID-19 shots in the 27-nation union, compared to the United States and former EU member Britain.

“We are ready to reflect with the member states on all possible avenues to indeed accelerate the approval of the vaccines,” an EU Commission spokesman told a news conference after the matter was discussed earlier on Tuesday at a COVID-19 meeting with EU Commission President Ursula von der Leyen.

One option could be “an emergency authorization of vaccines at EU level with shared liability among member states,” the spokesman said, adding that work on this could start very quickly if EU governments supported the idea.

It was not clear whether an EU-wide emergency authorization procedure, if agreed upon, would entail the same conditions as emergency approvals granted at national level, the commission spokesman told Reuters.

The European Medicines Agency (EMA) cannot currently issue emergency approvals but in exceptional circumstances has recommended the compassionate use of drugs before marketing authorization.

This procedure was used in April to initially authorize doctors to use Gilead’s antiviral drug remdesivir as a treatment against COVID-19. The drug was later given conditional approval by EMA.

CHANGE OF TACK

National emergency approvals are allowed under EU laws, but they force countries to take full responsibility if something goes wrong with a vaccine, whereas under the more rigorous marketing authorization, pharmaceutical companies remain liable for their vaccines.

The EU Commission had said that national emergency authorizations should not be used for COVID-19 vaccines because faster approvals could reduce regulators’ ability to check efficacy and safety data.

This could also boost vaccine hesitancy, which is already high in some countries, EU officials had said.

One senior EU official said the emergency procedure had so far usually been used at national level for terminally ill patients and the EU had instead chosen the lengthier conditional marketing authorization because with vaccines “we inject healthy people” and the risk was disproportionate.

The change of tack would come after Eastern European countries, including Hungary, Slovakia and the Czech Republic, approved or said they were considering approval of Russian and Chinese vaccines with national emergency procedures.

Britain has also used the emergency procedure to approve COVID-19 vaccines.

The EU Commission also said last month it was working on a possible fast-track approval of upgraded anti-variant vaccines, which had already been authorized and would need fewer comprehensive checks before they are made available to the public.

(Reporting by Francesco Guarascio @fraguarascio; additional reporting by Emilio Parodi; Editing by Nick Macfie and Jonathan Oatis)

Austria to isolate province in EU’s worst outbreak of South African coronavirus variant

By Francois Murphy

VIENNA (Reuters) – Austria is stepping up its response to the European Union’s biggest outbreak of the so-called South African coronavirus variant in its Alpine province of Tyrol, by requiring those leaving Tyrol to show a negative test result as of Friday.

A year ago Tyrol, a winter sports hotspot bordering Germany, Italy and Switzerland, was the scene of one of Europe’s worst instances of virus spreading at the ski resort of Ischgl. Thousands of tourists from across Europe were infected.

Despite that damaging episode, the provincial government has resisted pressure from Vienna to do more to curb the new variant that threatens Austria’s vaccination plans. After days of fraught negotiation, the national government said on Tuesday it would screen those leaving Tyrol, starting in three days.

“We have a responsibility throughout Austria to fight mutations against which vaccinations are less or maybe barely effective,” conservative Chancellor Sebastian Kurz told a news conference, a day after his government asked the public not to travel to Tyrol unless they have to.

Police will require anyone leaving the province to show a negative coronavirus test result no more than 48 hours old, and the measure will last 10 days. It will not apply to East Tyrol, which is separated from the rest of the province, or to children.

So far 293 cases of the variant have been confirmed in Tyrol, and 129 of them are currently active, the government said. The authorities have been unable to explain how it arrived in the province where lockdown measures have kept hotels closed to tourists, though ski lifts are open.

As in much of the EU, Austria’s national vaccination plan relies heavily on the AstraZeneca vaccine and a recent study has shaken confidence in its effectiveness against the South African variant, showing it had little effect against mild disease caused by that variant.

“Almost 50% of Europeans will be vaccinated with AstraZeneca in the coming months. If this drug is less effective then we must be aware that these mutations, that these variants, are extremely dangerous for us,” Kurz said.

On Monday, his government had loosened Austria’s third coronavirus lockdown, letting non-essential shops reopen, including in Tyrol, despite stubbornly high infections nationally.

The opposition Social Democrats criticized the bickering between the provincial and national governments, both of which are led by Kurz’s conservatives, saying in a statement they had “learned nothing from Ischgl”.

(Reporting by Francois Murphy; Editing by Alex Richardson and Grant McCool)

EU warns it could block vaccine exports, wields legal threat at drugmakers

By John Chalmers and Philip Blenkinsop

BRUSSELS (Reuters) – Europe’s fight to secure COVID-19 vaccine supplies intensified on Thursday when the European Union warned drug companies such as AstraZeneca that it would use all legal means or even block exports unless they agreed to deliver shots as promised.

The EU, whose member states are far behind Israel, the United Kingdom and the United States in rolling out vaccines, is scrambling to get supplies just as the West’s biggest drugmakers slow deliveries to the bloc due to production problems.

As vaccination centers in Germany, France and Spain cancelled or delayed appointments, the EU publicly rebuked Anglo-Swedish drugmaker AstraZeneca for failing to deliver and even asked if it could divert supplies from Britain.

European Council President Charles Michel said in a letter to four EU leaders that the EU should explore legal means to ensure supplies of COVID-19 vaccines it contracted to buy if negotiations with companies over delayed deliveries are unsuccessful.

“If no satisfactory solution can be found, I believe we should explore all options and make use of all legal means and enforcement measures at our disposal under the Treaties,” Michel said in the Jan. 27 letter.

EU rules on monitoring and authorizing exports of COVID-19 vaccines in the 27-nation bloc could lead to exports being blocked if they violated existing contracts between the vaccine maker and the EU, an EU official said.

The European Commission is to lay out the criteria under which such exports would be evaluated on Friday.

VACCINE CRUNCH

The swiftest mass vaccination drive in history is stoking tensions across the world as big powers buy up doses in bulk and poorer nations try to navigate a financial and diplomatic minefield to collect whatever supplies are left.

Israel is by far the world leader on vaccine rollout per head of population, followed by the United Arab Emirates, the United Kingdom, Bahrain and the United States. Behind them are Italy, Germany, France, China and Russia.

The African Union (AU) has secured another 400 million doses of the AstraZeneca COVID-19 vaccine, a regional health leader said on Thursday, in a push to immunize 60% of the continent’s population over three years.

Under fire from the EU, AstraZeneca CEO Pascal Soriot said the EU was late to strike a supply contract so the company did not have enough time to iron out production problems at a vaccine factory run by a partner in Belgium.

Tensions have risen as both New York-based Pfizer and AstraZeneca, headquartered in Cambridge, England, have had production problems.

Britain, which has repeatedly touted its lead in the vaccine rollout race since leaving the EU’s orbit on Jan. 1, said its deliveries must be honored.

“I think we need to make sure that the vaccine supply that has been bought and paid for, procured for those in the UK, is delivered,” Minister for the Cabinet Office Michael Gove told LBC Radio.

Just a day ahead of a decision by European regulators on whether to approve the drugmaker’s shot, Germany’s vaccine committee said AstraZeneca’s vaccine should only be given to people aged between 18 and 64.

“There are currently insufficient data available to assess the vaccine efficacy from 65 years of age,” the committee, also known as Stiko, said in a draft resolution made available by the health ministry on Thursday.

Britain’s Johnson said health authorities in Britain believed the vaccine was safe and worked across all age groups.

APPOINTMENTS CANCELLED

In the northern French region of Hauts-de-France, France’s second-most-densely-populated region, several vaccination centers were no longer taking appointments for a first jab. In several other French regions, some online appointment platforms closed booking options.

Spain’s Madrid region has ceased first vaccinations for at least this week and next and was using the few doses it has to administer second shots to those who have had the first one, said deputy regional government chief Ignacio Aguado.

Germany’s most populous state, North Rhine-Westphalia, last week postponed opening its vaccination centers until Feb. 8, while the state of Brandenburg has also had to push back vaccination appointments originally scheduled for the end of January due to delivery delays.

AstraZeneca is prepared to publish the delivery contract it has with the European Union and aims on Friday to make proposals to the European Commission on which sensitive parts to black out, the Frankfurter Allgemeine reported.

The newspaper quoted an EU source as saying that while AstraZeneca would not be able to deliver the 80 million doses expected for the first quarter, volumes should significantly exceed the 31 million doses that had earlier been reported.

(Reporting by Emma Thomasson and Paul Carrel in Berlin and Matthias Blamont in Paris and Kate Holton, Paul Sandle and Alistair Smout in London; writing by Guy Faulconbridge; editing by Keith Weir and Nick Macfie)

Brussels targets vaccinating at least 70% of EU adults by summer

BRUSSELS (Reuters) – European Union states should aim to vaccinate at least 70% of their adult populations against COVID-19 by the summer, the European Commission recommended on Tuesday.

Each of the EU’s 27 governments are managing their own vaccination campaigns, including their pace and which groups get priority. The Commission’s recommendations are not binding.

The 70% goal could mean inoculating over 200 million people, most likely with vaccines which need two doses per person. The EU has so far given a first dose to about 5 million people since it started its rollout at the end of December, the Commission said.

To meet its ambitious goal, the EU executive said it will work to boost the production capacity of vaccine makers with measures that could include investment in plants and faster regulatory procedures to authorize them.

As a mid-term target, by March at least 80% of people over the age of 80, and 80% of healthcare workers should also be vaccinated in each EU state, the Commission said.

The EU has ordered nearly 2.3 billion doses of approved and candidate COVID-19 vaccines, but only the shots developed by Moderna and Pfizer-BioNTech have so far received regulatory clearance in the bloc. They both need two doses to provide full protection.

The EU has secured 600 million doses of the vaccine developed by Pfizer and its German partner BioNTech and, despite early snags in deliveries, expects them to be delivered by the end of this year.

Moderna said it expects to deliver at least 80 million doses to the EU by the third quarter. Decisions on EU approvals of the vaccines developed by AstraZeneca and Johnson & Johnson are expected in coming weeks.

The Commission is also urging EU states to boost their capacity to sequence the coronavirus in order to detect new variants.

It called on EU governments to sequence at least 5% of all positive tests whereas at the moment many states test less than 1% of samples.

“Vaccinations will still take time until they reach all Europeans,” EU health commissioner Stella Kyriakides said, adding that meanwhile testing and sequencing must be increased.

The Commission also said it was working with EU states to adopt a common approach by the end of the month on vaccination certificates to facilitate travel.

(Reporting by Francesco Guarascio @fraguarascio; editing by Philip Blenkinsop, John Stonestreet, Philippa Fletcher, Alexandra Hudson)

EU kicks off debate on vaccine travel certificates

By Philip Blenkinsop

BRUSSELS (Reuters) – European Union countries kicked off a debate on Monday on whether people who have received a COVID-19 vaccine should have greater freedom to travel in the summer than those not immunized.

Europe ministers from the 27 EU nations held a video conference to discuss greater coordination for the roll-out of vaccines, a topic to be picked up by EU leaders who will meet online on Thursday.

Greek Prime Minister Kyriakos Mitsotakis floated the idea last week in a letter to the European Commission of an EU-wide vaccination certificate to help restore cross-border travel that has been crippled by the pandemic.

German Foreign Minister Heiko Maas said on Sunday that vaccinated people should be able to return sooner to restaurants and cinemas, although other ministers have criticized his view.

Maros Sefcovic, a European Commission vice president, said it was important to stress that vaccination is voluntary – some people were unable or unwilling to receive a vaccine.

Sefcovic told a news conference after Monday’s meeting such people should not have their rights limited. However, vaccination could become a condition for travel, like current requirements in many countries for a negative COVID test.

“There will be different options how we handle travel … the possibility of the electronic vaccination certificate could be added,” he said.

Michael Roth, representing Germany on Monday, said it was vital to establish if vaccinated people could still transmit the coronavirus to others.

The EU executive is working to ensure that vaccination data can be collected electronically in a common form.

The European Centre for Disease Prevention and Control will start collecting data from this week on vaccines delivered and vaccinations per country.

Sefcovic said EU countries needed to be largely synchronized to help keep open its single market, which allows freedom of movement of people and workers.

Many EU nations say they are receiving lower-than-expected supplies of COVID-19 vaccines and complain of uncertainty over future deliveries, EU officials have told Reuters.

(Reporting by Philip Blenkinsop; Editing by Giles Elgood)